{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:51:03Z","timestamp":1775872263984,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"DOI":"10.7759\/cureus.103554","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:54:53Z","timestamp":1771037693000},"source":"Crossref","is-referenced-by-count":1,"title":["Brentuximab-Induced Peripheral Neuropathy in the Setting of Radiation-Induced Brachial Plexopathy"],"prefix":"10.7759","author":[{"given":"Auden","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Masturov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Rekant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802973-2.00015-X","article-title":"Peripheral neuropathies","volume":"138","author":"Hanewinckel R","year":"2016","unstructured":"Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol. 2016, 138:263-82. 10.1016\/B978-0-12-802973-2.00015-X","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2024.09.026","article-title":"Radiation plexopathy","volume":"50","author":"Mosa A","year":"2025","unstructured":"Mosa A, Brogan DM, Dy CJ. Radiation plexopathy. J Hand Surg Am. 2025, 50:216-21. 10.1016\/j.jhsa.2024.09.026","journal-title":"J Hand Surg Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2024-106229","article-title":"Global estimates of prevalence of chronic painful neuropathy and moderate-to-severe neuropathy among patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of data from 29 countries between 2000 and 2024","author":"D'Souza RS","year":"2025","unstructured":"D'Souza RS, Saini C, Hussain N, Javed S, Prokop L, Her YF. Global estimates of prevalence of chronic painful neuropathy and moderate-to-severe neuropathy among patients with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of data from 29 countries between 2000 and 2024. Reg Anesth Pain Med. 2025, 10.1136\/rapm-2024-106229","journal-title":"Reg Anesth Pain Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny M","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, et al.. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014, 155:2461-70. 10.1016\/j.pain.2014.09.020","journal-title":"Pain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112671","article-title":"Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update","volume":"147","author":"Desforges AD","year":"2022","unstructured":"Desforges AD, Hebert CM, Spence AL, et al.. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update. Biomed Pharmacother. 2022, 147:112671. 10.1016\/j.biopha.2022.112671","journal-title":"Biomed Pharmacother"},{"key":"ref6","unstructured":"Brentuximab vedotin. (2018). Accessed. August 15, 2025: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/brentuximab-vedotin."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(73)93196-6","article-title":"The double crush in nerve entrapment syndromes","volume":"2","author":"Upton AR","year":"1973","unstructured":"Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet. 1973, 2:359-62. 10.1016\/s0140-6736(73)93196-6","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11420-010-9176-x","article-title":"Parsonage-turner syndrome","volume":"6","author":"Feinberg JH","year":"2010","unstructured":"Feinberg JH, Radecki J. Parsonage-turner syndrome. HSS J. 2010, 6:199-205. 10.1007\/s11420-010-9176-x","journal-title":"HSS J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian S","year":"2012","unstructured":"Delanian S, Lefaix JL, Pradat PF. Radiation-induced neuropathy in cancer survivors. Radiother Oncol. 2012, 105:273-82. 10.1016\/j.radonc.2012.10.012","journal-title":"Radiother Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi C","year":"2014","unstructured":"Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014, 58:1149-55. 10.1093\/cid\/ciu005","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09742-2","article-title":"Axonal variants of Guillain-Barr\u00e9 syndrome: an update","volume":"268","author":"Shang P","year":"2021","unstructured":"Shang P, Zhu M, Wang Y, et al.. Axonal variants of Guillain-Barr\u00e9 syndrome: an update. J Neurol. 2021, 268:2402-19. 10.1007\/s00415-020-09742-2","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001446.pub2","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","author":"Hughes RA","year":"2006","unstructured":"Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2006, 001446. 10.1002\/14651858.CD001446.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323124","article-title":"Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies","volume":"91","author":"Fargeot G","year":"2020","unstructured":"Fargeot G, Dupel-Pottier C, Stephant M, et al.. Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies. J Neurol Neurosurg Psychiatry. 2020, 91:786-8. 10.1136\/jnnp-2020-323124","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25254","article-title":"Microneurosurgical treatment options in peripheral nerve compression syndromes after chemotherapy and radiation treatment","volume":"118","author":"Chang EI","year":"2018","unstructured":"Chang EI, Rose MI, Rossi K, Elkwood AI. Microneurosurgical treatment options in peripheral nerve compression syndromes after chemotherapy and radiation treatment. J Surg Oncol. 2018, 118:793-9. 10.1002\/jso.25254","journal-title":"J Surg Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.773997","article-title":"Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin","volume":"54","author":"Pastorelli F","year":"2013","unstructured":"Pastorelli F, Derenzini E, Plasmati R, et al.. Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma. 2013, 54:2318-21. 10.3109\/10428194.2013.773997","journal-title":"Leuk Lymphoma"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-262139","article-title":"Severe subacute onset sensorimotor polyneuropathy associated with brentuximab vedotin treatment for refractory classical Hodgkin's lymphoma","volume":"17","author":"McNicholas N","year":"2024","unstructured":"McNicholas N, Hiew HJ, Arunachalam R, Osman C. Severe subacute onset sensorimotor polyneuropathy associated with brentuximab vedotin treatment for refractory classical Hodgkin's lymphoma. BMJ Case Rep. 2024, 17:262139. 10.1136\/bcr-2024-262139","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3180-x","article-title":"Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma","volume":"78","author":"Flerlage JE","year":"2016","unstructured":"Flerlage JE, Metzger ML, Wu J, Panetta JC. Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma. Cancer Chemother Pharmacol. 2016, 78:1217-23. 10.1007\/s00280-016-3180-x","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29801","article-title":"Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: results of a real-life study","volume":"69","author":"Massano D","year":"2022","unstructured":"Massano D, Carraro E, Mussolin L, et al.. Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: results of a real-life study. Pediatr Blood Cancer. 2022, 69:29801. 10.1002\/pbc.29801","journal-title":"Pediatr Blood Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03177-8","article-title":"Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report","volume":"23","author":"Park C","year":"2023","unstructured":"Park C, Kim KT. Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report. BMC Neurol. 2023, 23:130. 10.1186\/s12883-023-03177-8","journal-title":"BMC Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms, and treatment","volume":"9","author":"Burgess J","year":"2021","unstructured":"Burgess J, Ferdousi M, Gosal D, et al.. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms, and treatment. Oncol Ther. 2021, 9:385-450. 10.1007\/s40487-021-00168-y","journal-title":"Oncol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457253-brentuximab-induced-peripheral-neuropathy-in-the-setting-of-radiation-induced-brachial-plexopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:54:54Z","timestamp":1771037694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457253-brentuximab-induced-peripheral-neuropathy-in-the-setting-of-radiation-induced-brachial-plexopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103554","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}